Bactericidal activity of moxifloxacin against Staphylococcus aureus

被引：5

作者：

Berrington, AW ^{[1
]}

Perry, JD ^{[1
]}

Gould, EK ^{[1
]}

机构：

[1] Freeman Hosp, Dept Microbiol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2001年 / 7卷 / 03期

关键词：

D O I：

10.1046/j.1469-0691.2001.00223.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

In summary, it is clear that among sensitive strains of S. aureus, moxifloxacin is bactericidal at clinically achievable levels. These observations support the potential of moxifloxacin in the treatment of deep-seated infections caused by ciprofloxacin-sensitive strains of S. aureus.

引用

页码：161 / 163

页数：3

共 11 条

[1] Intracellular activity of ciprofloxacin and moxifloxacin, a new 8-methoxyquinolone, against methicillin-resistant Staphylococcus aureus [J].

Al-Nawas, B ;

Shah, PM .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (06) :655-658

[2] MEDICAL-TREATMENT OF INFECTIVE ENDOCARDITIS - GENERAL-PRINCIPLES [J].

BESNIER, JM ;

CHOUTET, P .

EUROPEAN HEART JOURNAL, 1995, 16 :72-74

[3] In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against and Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis [J].

Brueggemann, AB ;

Kugler, KC ;

Doern, GV .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) :1594-1597

[4]

DURHAM EJ, 1997, 37 INT C ANT AG CHEM, P169

[5] Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains [J].

Jones, ME ;

Visser, MR ;

Klootwijk, M ;

Heisig, P ;

Verhoef, J ;

Schmitz, FJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) :421-423

[6] Glycopeptide tolerance in bacteria causing endocarditis [J].

Perry, JD ;

Jones, AL ;

Gould, FK .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (01) :121-124

[7]

Simmons NA, 1998, HEART, V79, P207

[8] Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects [J].

Stass, H ;

Dalhoff, A ;

Kubitza, D ;

Schühly, U .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :2060-2065

[9] Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci [J].

von Eiff, C ;

Peters, G .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) :569-573

[10] In vitro activity of BAY 12-8039, a new fluoroquinolone [J].

Woodcock, JM ;

Andrews, JM ;

Boswell, FJ ;

Brenwald, NP ;

Wise, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :101-106

← 1 2 →